May 5, 2016: WAVE Life Sciences today announced that it has entered into a research, license and option agreement with Pfizer for the potential development of nucleic acid therapies aimed at silencing the underlying causes of debilitating metabolic diseases.
May 5, 2016: Enters definitive agreement to acquire Euticals for $358M in stock, cash and a seller note
Positions AMRI as one of the largest independent developers and suppliers of API to the pharma industry.
May 5, 2016: Sanofi sees a strong strategic fit with Medivation even though its tie-up proposal was rejected by the U.S. cancer drug maker last week, the company's chief executive said on Wednesday. The French drugmaker went public with a $9.3B proposal to buy Medivation on April 28.
May 5, 2016: All biotech companies have a budget for R&D of new therapeutics or other products intended to help stymie an illness in some way. But, the Boston Business Journal recently compiled a list of the 10 pharma and biotech companies...